Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
0.8410
-0.0342 (-3.91%)
At close: Nov 17, 2026, 4:00 PM EST
0.922949
+0.0819 (9.74%)
After-hours: Nov 17, 2026, 4:17 PM EST

Allarity Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.350.32----
Revenue Growth
------
Gross Profit
0.350.32----
Operating Income
-13.78-12.61-17.54-17.13-16.89-26.56
Net Income
-15.73-11.23-25.15-20.42-21.05-26.65
Earnings Per Share
-0.99-0.78-15.65---
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.0914.7719.610.222.0819.96
Total Debt
23.021.41.351.33.741.09
Net Cash (Debt)
-8.9313.3718.26-1.08-1.6618.87
Net Cash Growth
--26.76%----
Net Cash Per Share
-0.560.9311.36---

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-13.18-14.82-17.35-12.75-16.82-14.89
Capital Expenditures
-0.07-0.01-0.3--0.02-
Free Cash Flow
-13.25-14.83-17.65-12.75-16.84-14.89
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%----
Operating Margin
-3938.29%-3939.06%----
Pretax Margin
-4493.71%-3509.69%----
Profit Margin
-4493.71%-3509.69%----
FCF Margin
-3785.43%-4633.75%----

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
38.2353.33----